The CD90-positivity of JUNB-overexpressing hepatoma cells increased from 0.6% to 3.4% for Huh1, from 0.1% to 18.0% for Huh7, and from 0.9% to 2.3% for patient HCC (Fig. 4D). Here, JUNB is linked to hepatocellular carcinoma.